BillionToOne, Inc. 是一間精準診斷公司,透過量化生物學來開發分子診斷產品。公司總部位於加州門洛帕克。
財務指標
營業收入
2026-06-30
$109.44M
2026-03-31
$108.38M
2025-12-31
$96.05M
2025-09-30
$83.52M
營業支出
2026-06-30
$71.6M
2026-03-31
$61.26M
2025-12-31
$58.27M
2025-09-30
$48.78M
淨利潤
2026-06-30
$8.05M
2026-03-31
$17.97M
2025-12-31
$5.97M
2025-09-30
$1.5M
淨利潤率
2026-06-30
7.35%
2026-03-31
16.57%
2025-12-31
6.22%
2025-09-30
1.8%
每股收益
2026-06-30
$0.15
2026-03-31
$0.33
2025-12-31
$0.15
2025-09-30
$0.91
息稅折舊攤銷前利潤
2026-06-30
$10.92M
2026-03-31
$21.5M
2025-12-31
$9.26M
2025-09-30
$8.55M
有效稅率
2026-06-30
-7.12%
2026-03-31
2.91%
2025-12-31
5.08%
2025-09-30
-2.31%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$109.44M
$108.38M
$96.05M
$83.52M
營業支出
$71.6M
$61.26M
$58.27M
$48.78M
淨利潤
$8.05M
$17.97M
$5.97M
$1.5M
淨利潤率
7.35%
16.57%
6.22%
1.8%
每股收益
$0.15
$0.33
$0.15
$0.91
息稅折舊攤銷前利潤
$10.92M
$21.5M
$9.26M
$8.55M
有效稅率
-7.12%
2.91%
5.08%
-2.31%
常見問題
BLLN stock represents a publicly traded security listed on a U.S. exchange, giving investors exposure to the underlying company's business operations. Because no specific company details have been provided here, the most reliable way to understand what BLLN stock represents is to review the company profile, sector classification, and business description shown on this page.
BLLN's share price can be influenced by company-specific developments such as quarterly earnings, revenue trends, and management guidance, as well as broader market conditions like investor sentiment, sector rotation, and macroeconomic changes. Interest rate expectations, industry competition, and regulatory developments may also affect how the market values BLLN. Reviewing the latest BLLN news and financial disclosures can help investors understand which factors are currently most relevant.
Recent performance for BLLN depends on current market trading, so the most accurate figures are the latest price, daily change, and historical performance data displayed on this page. That data typically includes recent trading sessions, short-term trends, and longer-term comparisons. Investors often review these figures alongside volume and broader market benchmarks to assess how BLLN has been behaving relative to peers and the overall market.
Common valuation metrics for analyzing BLLN include the price-to-earnings (P/E) ratio, price-to-sales (P/S), price-to-book (P/B), and enterprise value multiples such as EV/EBITDA. Investors may also compare BLLN's metrics with those of industry peers and its own historical averages. These measures should be considered together, since a single metric rarely provides a complete picture of whether a stock is reasonably valued.
To buy BLLN stock, investors generally need a brokerage account that supports U.S. equity trading. Once the account is funded, BLLN can be purchased through the broker's platform using a market order or a limit order, depending on the preferred execution method. Availability of fractional shares and any applicable commissions or fees varies by broker, so reviewing the broker's terms before placing a trade is advisable.
Investing in BLLN carries risks such as market volatility, where the share price may decline due to broad market downturns or changing investor sentiment. Company-specific risks can include weaker-than-expected financial results, operational challenges, competitive pressure, or regulatory developments affecting its business. Investors should also consider liquidity risk and valuation risk, especially if BLLN's stock price has moved sharply. Reviewing BLLN's risk disclosures and financial statements can help clarify these factors.